StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

MariMed's operating income for the twelve months ending Sep 30, 2026 was -$2.76M, down 1265.0% year over year. For fiscal 2025 it was -$2.82M, down 208.1% from the year before. The highest annual figure on record is $26.86M in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.82M-208.1%
FY2024Dec 31, 2024$2.61M-81.9%
FY2023Dec 31, 2023$14.39M-29.4%
FY2022Dec 31, 2022$20.37M-24.2%
FY2021Dec 31, 2021$26.86M+84.9%
FY2020Dec 31, 2020$14.53M–
FY2019Dec 31, 2019-$41.53M–
FY2018Dec 31, 2018-$5.36M-4295.9%
FY2017Dec 31, 2017$127.65K-83.5%
FY2016Dec 31, 2016$775.30K–
FY2015Dec 31, 2015-$1.69M–
FY2014Dec 31, 2014-$817.35K–
FY2013Dec 31, 2013-$558.15K–
FY2012Dec 31, 2012-$774.79K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$1.22M-23.6%
Q2 FY2026Jun 30, 2026$418.00K-58.9%
Q1 FY2026Mar 31, 2026$125.00K–
Q4 FY2025Dec 31, 2025-$4.53M–
Q3 FY2025Sep 30, 2025$1.60M+18.9%
Q2 FY2025Jun 30, 2025$1.02M+6.3%
Q1 FY2025Mar 31, 2025-$910.00K-145.0%
Q4 FY2024Dec 31, 2024-$1.47M-160.9%
Q3 FY2024Sep 30, 2024$1.35M-59.1%
Q2 FY2024Jun 30, 2024$956.00K-73.0%
Q1 FY2024Mar 31, 2024$2.02M-60.6%
Q4 FY2023Dec 31, 2023$2.41M-21.9%
Q3 FY2023Sep 30, 2023$3.29M-42.6%
Q2 FY2023Jun 30, 2023$3.55M-21.1%
Q1 FY2023Mar 31, 2023$5.14M-27.2%
Q4 FY2022Dec 31, 2022$3.09M+156.8%
Q3 FY2022Sep 30, 2022$5.74M-18.5%
Q2 FY2022Jun 30, 2022$4.50M-44.1%
Q1 FY2022Mar 31, 2022$7.05M+107.4%
Q4 FY2021Dec 31, 2021$1.20M-42.7%
Q1 FY2021Mar 31, 2021$7.04M+598.7%
Q4 FY2020Dec 31, 2020$8.04M–
Q3 FY2020Sep 30, 2020$3.40M+249.4%
Q2 FY2020Jun 30, 2020$2.10M-60.8%
Q1 FY2020Mar 31, 2020$1.01M–
Q4 FY2019Dec 31, 2019-$47.64M–
Q3 FY2019Sep 30, 2019$972.63K–
Q2 FY2019Jun 30, 2019$5.35M+1112.9%
Q1 FY2019Mar 31, 2019-$222.28K–
Q4 FY2018Dec 31, 2018-$4.94M–
Q3 FY2018Sep 30, 2018-$548.99K-291.3%
Q2 FY2018Jun 30, 2018$441.04K-26.6%
Q1 FY2018Mar 31, 2018-$321.64K-240.7%
Q4 FY2017Dec 31, 2017-$989.06K-262.0%
Q3 FY2017Sep 30, 2017$287.04K+421.5%
Q2 FY2017Jun 30, 2017$601.12K–
Q1 FY2017Mar 31, 2017$228.55K–
Q4 FY2016Dec 31, 2016$610.52K–
Q3 FY2016Sep 30, 2016$55.04K–

More MariMed figures

See a number that looks wrong?